ULTRAZYME PLUS GPT

Nadh Oxidation/nad Reduction, Alt/sgpt

HARLECO DIAGNOSTICS

The following data is part of a premarket notification filed by Harleco Diagnostics with the FDA for Ultrazyme Plus Gpt.

Pre-market Notification Details

Device IDK821882
510k NumberK821882
Device Name:ULTRAZYME PLUS GPT
ClassificationNadh Oxidation/nad Reduction, Alt/sgpt
Applicant HARLECO DIAGNOSTICS 803 N. Front St. Suite 3 Mchenry,  IL  60050
Product CodeCKA  
CFR Regulation Number862.1030 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1982-06-25
Decision Date1982-07-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.